T. Rowe Price Associates, Inc. 13D and 13G filings for Nevro Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Nevro Corp. NVRO | T. Rowe Price Associates, Inc. | 280,434 0.700% | -2,048,097 (-87.96%) | Filing |
| 2022-01-10 2:12 pm Sale | 2021-12-31 | 13G | Nevro Corp. NVRO | T. Rowe Price Associates, Inc. | 2,328,531 6.600% | -1,699,789 (-42.20%) | Filing |
| 2021-02-16 12:23 pm Purchase | 2020-12-31 | 13G | Nevro Corp. NVRO | T. Rowe Price Associates, Inc. | 4,028,320 11.700% | 278,124 (+7.42%) | Filing |
| 2020-03-10 1:10 pm Purchase | 2020-02-29 | 13G | Nevro Corp. NVRO | T. Rowe Price Associates, Inc. | 3,750,196 11.700% | 1,067,358 (+39.78%) | Filing |
| 2020-02-14 1:30 pm Sale | 2019-12-31 | 13G | Nevro Corp. NVRO | T. Rowe Price Associates, Inc. | 2,682,838 8.600% | -395,776 (-12.86%) | Filing |